Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection
{{output}}
The development of new immunosuppressive drugs for kidney transplantation resulted both in better short-term outcomes and in decreased metabolic, cardiovascular, and nephrotoxicity risk. Belatacept belongs to a new class of immunosuppressive drugs that selecti... ...
